Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/17/2025

Pain Management in Elderly Patients

Initial Pharmacotherapy

  • The American Geriatrics Society recommends acetaminophen as initial and ongoing pharmacotherapy for pain management in elderly patients, rather than NSAIDs, due to their significant risks 1
  • Maximum daily recommended dosage of acetaminophen should not exceed 4g per 24 hours and must include "hidden sources" from combination medications 1
  • Acetaminophen 650 mg every 6 hours (maximum 3g/day) is recommended as a first-line approach for pain management in elderly patients, with lower maximum dose than standard adult recommendations due to age-related hepatic concerns 2, 3

NSAID Use in Elderly Patients

  • NSAIDs should be considered rarely and only in highly selected elderly individuals due to their high risk profile 1
  • The American Geriatrics Society recommends avoiding NSAIDs in patients with renal function impairment, cardiovascular disease, gastrointestinal risk factors, and hypertension 1
  • Naproxen may have the most favorable cardiovascular risk profile among traditional NSAIDs, while diclofenac has the highest cardiovascular risk 4
  • Celecoxib (COX-2 selective inhibitor) may be considered with a proton pump inhibitor for patients with low cardiovascular risk but higher GI risk 5
  • Age over 60 years is considered a major risk factor for NSAID-related complications, with risks increasing substantially in patients over 75 years, and particularly pronounced at 90 years old 1, 6, 2

Concomitant Medications and Monitoring

  • Avoid ibuprofen in patients taking aspirin for cardioprophylaxis, as it interferes with aspirin's antiplatelet effect 1, 4
  • Add gastroprotection with a proton pump inhibitor or misoprostol for all elderly patients taking NSAIDs 1, 5
  • Routinely monitor for GI toxicity, renal function, hypertension, and heart failure in elderly patients taking NSAIDs 1
  • Monitoring of liver function is recommended if acetaminophen is used chronically 2, 3
  • Baseline and follow-up blood pressure measurements, as well as baseline and periodic laboratory tests, including BUN and creatinine, liver function tests, complete blood count, and fecal occult blood test, are recommended when using NSAIDs in elderly patients 2
  • Monitoring for signs of hypertension, edema, GI symptoms, and mental status changes is also necessary when using NSAIDs in elderly patients

Adverse Events and Interactions

  • NSAIDs were implicated in 23.5% of adverse drug reaction hospitalizations in older adults, highlighting the importance of cautious prescribing and close monitoring 1
  • Renal toxicity, gastrointestinal toxicity, and cardiovascular toxicity are high-risk factors for patients over 60 years, increasing the risk of renal complications, GI bleeding and ulceration, and cardiovascular events, respectively 2, 1, 7
  • The 2019 AGS Beers Criteria explicitly identifies NSAIDs as potentially inappropriate medications in older adults due to increased risk of GI bleeding/peptic ulcer disease and acute kidney injury 6
  • NSAIDs can interact dangerously with anticoagulants, ACE inhibitors, diuretics, and antiplatelets, increasing the risk of bleeding and worsening renal function 7
  • Frailty is a contraindication for NSAID use in elderly patients, according to the OARSI guidelines 8

Alternative Therapies

  • Topical NSAIDs, such as diclofenac gel/patch, can be considered for localized relief with minimal systemic absorption, particularly useful for localized joint pain 1, 8
  • Non-pharmacological approaches, such as physical therapy, weight management, and assistive devices, may provide relief without medication risks
  • If systemic treatment is necessary, short-term use only (maximum 7 days for non-selective NSAIDs) is recommended, with the lowest effective dose of the safest NSAID (ibuprofen preferred) and mandatory gastroprotection with proton pump inhibitor 8, 9
  • Close monitoring of renal function, blood pressure, and signs of GI bleeding is required when using systemic NSAIDs 2, 9